ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume 29, Issue 4, Pages 728-760
Publisher
BMJ
Online
2019-05-03
DOI
10.1136/ijgc-2019-000308
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Editorial
- (2018) C Fotopoulou et al. ANNALS OF ONCOLOGY
- Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
- (2018) Lydia Giannopoulou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer
- (2018) Roberto Tozzi et al. GYNECOLOGIC ONCOLOGY
- Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type
- (2018) Sebastien Gouy et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Trial of Optimal Personalised Care After Treatment—Gynaecological Cancer (TOPCAT-G)
- (2018) Val Morrison et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)
- (2018) Helena M. Ditzel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols
- (2018) Melanie Calvert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic indicators in ovarian serous borderline tumours
- (2018) Anais Malpica et al. PATHOLOGY
- Endometriosis-associated ovarian neoplasia
- (2018) Xavier Matias-Guiu et al. PATHOLOGY
- A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study.
- (2018) Robert L. Coleman et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy plus or minus bevacizumab for platinum-sensitive ovarian cancer patients recurring after a bevacizumab containing first line treatment: The randomized phase 3 trial MITO16B-MaNGO OV2B-ENGOT OV17.
- (2018) Sandro Pignata et al. JOURNAL OF CLINICAL ONCOLOGY
- 933OCarboplatin/pegylated liposomal doxorubicin/bevacizumab (CD-BEV) vs. carboplatin/gemcitabine/bevacizumab (CG-BEV) in patients with recurrent ovarian cancer: A prospective randomized phase III ENGOT/GCIG-Intergroup study (AGO study group, AGO-Austria, ANZGOG, GINECO, SGCTG)
- (2018) J Pfisterer et al. ANNALS OF ONCOLOGY
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
- (2017) Katrijn Michielsen et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial
- (2017) Roman Rouzier et al. EUROPEAN JOURNAL OF CANCER
- Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer
- (2017) Florence Joly et al. EUROPEAN JOURNAL OF CANCER
- Comparison of 18F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study
- (2017) Lino M. Sawicki et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice
- (2017) Christina Fotopoulou et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review
- (2017) Giuseppe Scaletta et al. Expert Review of Anticancer Therapy
- Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors
- (2017) Kobe Dewilde et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience
- (2017) Heather J. Dalton et al. GYNECOLOGIC ONCOLOGY
- FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper
- (2017) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
- Is it necessary to perform routine appendectomy for mucinous ovarian neoplasms? A retrospective study and meta-analysis
- (2017) Aoshuang Cheng et al. GYNECOLOGIC ONCOLOGY
- Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
- (2017) Amanda N. Fader et al. GYNECOLOGIC ONCOLOGY
- An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
- (2017) Ritu Salani et al. GYNECOLOGIC ONCOLOGY
- Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2
- (2017) Amit M. Oza et al. GYNECOLOGIC ONCOLOGY
- High-grade serous carcinoma of tubo-ovarian origin: recent developments
- (2017) Naveena Singh et al. HISTOPATHOLOGY
- The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma
- (2017) Priya Singh et al. HISTOPATHOLOGY
- Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al
- (2017) Philipp Harter et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma
- (2017) Edwina Coghlan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
- (2017) Denis Querleu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian Cancer Follow-up
- (2017) Anne Lanceley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma
- (2017) W. Glenn McCluggage et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
- (2017) Ethan Basch et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum
- (2017) David M. Gershenson et al. JOURNAL OF CLINICAL ONCOLOGY
- External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
- (2017) Jung-Yun Lee et al. Journal of Gynecologic Oncology
- Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses
- (2017) Carlos Bais et al. JNCI-Journal of the National Cancer Institute
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
- (2017) Robert L Coleman et al. LANCET ONCOLOGY
- Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging
- (2017) Naveena Singh et al. MODERN PATHOLOGY
- Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer
- (2017) Allison Gockley et al. OBSTETRICS AND GYNECOLOGY
- Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study
- (2017) Felicia T. Roncolato et al. ONCOLOGIST
- Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer
- (2017) Madeleine T. King et al. QUALITY OF LIFE RESEARCH
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
- (2017) Saeed Rafii et al. Oncotarget
- Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses
- (2017) Carlos Bais et al. JNCI-Journal of the National Cancer Institute
- CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
- (2017) Josephine B. Walton et al. Scientific Reports
- Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
- (2016) Dirk Timmerman et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy
- (2016) Eun Ji Han et al. ANNALS OF NUCLEAR MEDICINE
- Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
- (2016) K. Lindemann et al. ANNALS OF ONCOLOGY
- Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues
- (2016) E. Bentivegna et al. ANNALS OF ONCOLOGY
- Patient-reported outcomes (PRO) in ovarian cancer clinical trials—lost opportunities and lessons learned: Table 1.
- (2016) M. Friedlander et al. ANNALS OF ONCOLOGY
- Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities
- (2016) Christina Fotopoulou et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study
- (2016) Katrijn L M Michielsen et al. BRITISH JOURNAL OF RADIOLOGY
- Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
- (2016) Bradley J. Monk et al. CURRENT PHARMACEUTICAL DESIGN
- A phase III trial of bevacizumab with IV versus IP chemotherapy for ovarian, fallopian tube, and peritoneal carcinoma: An NRG Oncology Study
- (2016) J. Walker et al. GYNECOLOGIC ONCOLOGY
- Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
- (2016) Jacek P. Grabowski et al. GYNECOLOGIC ONCOLOGY
- Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
- (2016) Naveena Singh et al. GYNECOLOGIC ONCOLOGY
- The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Oncology Group trials
- (2016) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
- (2016) Susan M. Domchek et al. GYNECOLOGIC ONCOLOGY
- Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT)
- (2016) Nikoline Marie Schou Karlsen et al. GYNECOLOGIC ONCOLOGY
- Heated IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent Ovarian Cancer
- (2016) Alexander Hotouras et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Activity of Bevacizumab in Patients With Low-Grade Serous Ovarian Carcinoma
- (2016) Peter G. Rose et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer
- (2016) György Sölétormos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
- (2016) Denis Querleu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- How to Select Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients With Stage IIIC or IV Ovarian Carcinoma
- (2016) Ignace B. Vergote et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alexi A. Wright et al. JOURNAL OF CLINICAL ONCOLOGY
- Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
- (2016) John K. Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer
- (2016) Sudeshna Chatterjee et al. OBSTETRICS AND GYNECOLOGY
- Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria
- (2016) Steffen Hauptmann et al. VIRCHOWS ARCHIV
- Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube
- (2016) M. A. Eckert et al. Cancer Discovery
- Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
- (2016) Neil Lineberry et al. BMJ-British Medical Journal
- Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
- (2016) Neil Lineberry et al. BMJ-British Medical Journal
- Incidental Serous Tubal Intraepithelial Carcinoma and Early Invasive Serous Carcinoma in the Nonprophylactic Setting
- (2015) Jane C. Morrison et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases
- (2015) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
- (2015) K. S. Tewari et al. ANNALS OF ONCOLOGY
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
- (2015) N. I. Cherny et al. ANNALS OF ONCOLOGY
- New Pointers for Surgical Staging of Borderline Ovarian Tumors
- (2015) Sofiane Bendifallah et al. ANNALS OF SURGICAL ONCOLOGY
- What Should We Expect After a Complete Cytoreduction at the Time of Interval or Primary Debulking Surgery in Advanced Ovarian Cancer?
- (2015) Luis Chiva et al. ANNALS OF SURGICAL ONCOLOGY
- Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013
- (2015) Jaime Prat BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- 18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer
- (2015) J J You et al. BRITISH JOURNAL OF CANCER
- Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors
- (2015) Ines Vasconcelos et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients
- (2015) Enrica Bentivegna et al. FERTILITY AND STERILITY
- The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
- (2015) Erin K. Crane et al. GYNECOLOGIC ONCOLOGY
- A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer
- (2015) Luis M. Chiva et al. GYNECOLOGIC ONCOLOGY
- Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group
- (2015) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
- (2015) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum
- (2015) Naveena Singh et al. HISTOPATHOLOGY
- Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
- (2015) Steffen Böhm et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial
- (2015) Rosalind A. Eeles et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
- (2015) Andres M. Poveda et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- (2015) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2015) Devansu Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- Surveillance and Care of the Gynecologic Cancer Survivor
- (2015) Stephanie S. Faubion et al. JOURNAL OF WOMENS HEALTH
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
- (2015) W Glenn McCluggage et al. MODERN PATHOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- A Meta-Analysis on the Impact of Platinum-Based Adjuvant Treatment on the Outcome of Borderline Ovarian Tumors With Invasive Implants
- (2015) I. Vasconcelos et al. ONCOLOGIST
- The secondary Müllerian system, field effect, BRCA, and tubal fimbria: our evolving understanding of the origin of tubo-ovarian high-grade serous carcinoma and why assignment of primary site matters
- (2015) Naveena Singh et al. PATHOLOGY
- General practitioners’ attitudes toward follow-up after cancer treatment: A cross-sectional questionnaire study
- (2015) Heidi Lidal Fidjeland et al. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE
- Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer
- (2015) Xingang Peng et al. World Journal of Surgical Oncology
- Ultrasound in Gynecological Cancer: Is It Time for Re-evaluation of Its Uses?
- (2015) Daniela Fischerova et al. Current Oncology Reports
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Early Detection of High-grade Tubal Serous Carcinoma in Women at Low Risk for Hereditary Breast and Ovarian Cancer Syndrome by Systematic Examination of Fallopian Tubes Incidentally Removed During Benign Surgery
- (2014) Joseph T. Rabban et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments
- (2014) C. Uzan et al. ANNALS OF ONCOLOGY
- Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
- (2014) F. Trillsch et al. ANNALS OF ONCOLOGY
- Optimal treatment of early-stage ovarian cancer
- (2014) F. Collinson et al. ANNALS OF ONCOLOGY
- The Combination of Circulating Ang1 and Tie2 Levels Predicts Progression-Free Survival Advantage in Bevacizumab-Treated Patients with Ovarian Cancer
- (2014) A. Backen et al. CLINICAL CANCER RESEARCH
- Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer
- (2014) M.E.L. van der Burg et al. EUROPEAN JOURNAL OF CANCER
- The role of palliative colorectal stents in gynaecologic malignancy
- (2014) Leah Jutzi et al. GYNECOLOGIC ONCOLOGY
- Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer
- (2014) Rachel N. Grisham et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Low-Grade Serous Tumors of Ovary
- (2014) Debra A. Bell INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Primary Ovarian Mucinous Adenocarcinoma of Intestinal Type
- (2014) Surapan Khunamornpong et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer
- (2014) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2014) Robert A. Burger et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture
- (2014) Dai Shimizu et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
- (2014) Sandro Pignata et al. LANCET ONCOLOGY
- Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis
- (2013) Hyun Jong Park et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary
- (2013) C. Uzan et al. ANNALS OF ONCOLOGY
- Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity
- (2013) I. Bajrami et al. CANCER RESEARCH
- Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection
- (2013) F. Collinson et al. CLINICAL CANCER RESEARCH
- Predictive Biomarkers for Bevacizumab: Are We There Yet?
- (2013) D. Maru et al. CLINICAL CANCER RESEARCH
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
- (2013) Kathryn P. Pennington et al. CLINICAL CANCER RESEARCH
- Bowel obstruction in recurrent gynecologic malignancies: Defining who will benefit from surgical intervention
- (2013) T. Perri et al. EJSO
- Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group
- (2013) Andreas du Bois et al. EUROPEAN JOURNAL OF CANCER
- Primary invasive mucinous ovarian carcinoma of the intestinal type: Importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases
- (2013) K. Muyldermans et al. EUROPEAN JOURNAL OF CANCER
- Outcome differences in patients with advanced epithelial ovarian, primary peritoneal and fallopian tube cancers treated with and without bevacizumab
- (2013) L. Randall et al. GYNECOLOGIC ONCOLOGY
- Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants
- (2013) Alexandra Leary et al. GYNECOLOGIC ONCOLOGY
- A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age
- (2013) Hiroaki Kajiyama et al. International Journal of Clinical Oncology
- Salvage Surgery Due To Bowel Obstruction in Advanced or Relapsed Ovarian Cancer Resulting in Short Bowel Syndrome and Long-Life Total Parenteral Nutrition
- (2013) Christina Fotopoulou et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer
- (2013) Xiaoxiang Chen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling
- (2013) Ali Bashashati et al. JOURNAL OF PATHOLOGY
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
- (2013) Noriyuki Katsumata et al. LANCET ONCOLOGY
- Survival in Women With Grade 1 Serous Ovarian Carcinoma
- (2013) Amanda Nickles Fader et al. OBSTETRICS AND GYNECOLOGY
- Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
- (2012) R. Fruscio et al. ANNALS OF ONCOLOGY
- Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation
- (2012) Christina Fotopoulou et al. ANNALS OF SURGICAL ONCOLOGY
- Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome
- (2012) Nour Sneige et al. CANCER CYTOPATHOLOGY
- Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: Analysis of prospective randomised phase III trials
- (2012) S. Mahner et al. EUROPEAN JOURNAL OF CANCER
- Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study
- (2012) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer
- (2012) Rebecca Byler Dann et al. GYNECOLOGIC ONCOLOGY
- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
- (2012) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?
- (2012) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options
- (2012) Emile Daraï et al. HUMAN REPRODUCTION UPDATE
- Impact of Routine Follow-Up Examinations on Life Expectancy in Ovarian Cancer Patients
- (2012) Sandra M. E. Geurts et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary
- (2012) Toshio Takada et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma
- (2012) Mika Mizuno et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2012) Kathryn Alsop et al. JOURNAL OF CLINICAL ONCOLOGY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence
- (2012) Philippe Morice et al. LANCET ONCOLOGY
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Behavior of Serous Borderline Ovarian Tumors With and Without Micropapillary Patterns: Results of a French Multicenter Study
- (2011) R. Fauvet et al. ANNALS OF SURGICAL ONCOLOGY
- Low-grade serous primary peritoneal carcinoma
- (2011) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study
- (2011) Robert S. Mannel et al. GYNECOLOGIC ONCOLOGY
- Accuracy of frozen section diagnosis of ovarian borderline tumor
- (2011) K.K. Shih et al. GYNECOLOGIC ONCOLOGY
- Micropapillary pattern in serous borderline ovarian tumors: Does it matter?
- (2011) Jeong-Yeol Park et al. GYNECOLOGIC ONCOLOGY
- Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: Implications for surgical staging
- (2011) Cecelia A. Powless et al. GYNECOLOGIC ONCOLOGY
- No Supportive Evidence for Clinical Benefit of Routine Follow-Up in Ovarian Cancer
- (2011) Sandra M.E. Geurts et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Considering Early Detection of Relapsed Ovarian Cancer
- (2011) Sandra M.E. Geurts et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Fertility-Sparing Surgery for Borderline Ovarian Tumors
- (2011) Taejong Song et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer
- (2011) Philipp Harter et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Surgical and Medical Treatment of Clear Cell Ovarian Cancer
- (2011) Francescapaola Magazzino et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
- (2011) Gordon John Sampson Rustin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Trials in Recurrent Ovarian Cancer
- (2011) Michael Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer
- (2011) Gavin C.E. Stuart et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
- (2011) Elisabetta Kuhn et al. JOURNAL OF PATHOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- BRCA Mutation Status and Determinant of Outcome in Women with Recurrent Epithelial Ovarian Cancer Treated with Pegylated Liposomal Doxorubicin
- (2011) T. Safra et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer
- (2010) J. A. Ledermann et al. CLINICAL CANCER RESEARCH
- Understanding the problem of inadequately staging early ovarian cancer
- (2010) P.J. Timmers et al. EUROPEAN JOURNAL OF CANCER
- Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary
- (2010) Aminata Kane et al. FERTILITY AND STERILITY
- The role of restaging borderline ovarian tumors: Single institution experience and review of the literature
- (2010) Ignacio Zapardiel et al. GYNECOLOGIC ONCOLOGY
- Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up
- (2010) S. Palomba et al. HUMAN REPRODUCTION
- Is There a High-Risk Subgroup of Stage I Epithelial Ovarian Cancer That Is Most Likely to Benefit From 6 Versus 3 Cycles of Adjuvant Chemotherapy?
- (2010) Jamie N. Bakkum-Gamez et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
- (2010) Helen J. Mackay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
- (2010) Ali Dastranj Tabrizi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection
- (2010) Toyomi Satoh et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical Staging and Treatment of Early Ovarian Cancer: Long-term Analysis From a Randomized Trial
- (2010) B. Trimbos et al. JNCI-Journal of the National Cancer Institute
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary
- (2009) C. Uzan et al. ANNALS OF ONCOLOGY
- Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy
- (2009) Jean-Luc Brun et al. BMC CANCER
- CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers
- (2009) Chunqiao Tian et al. CANCER
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
- (2009) Andreas du Bois et al. CANCER
- The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study
- (2009) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Prognostic Factors in Patients with Ovarian Serous Low Malignant Potential (Borderline) Tumors with Peritoneal Implants
- (2009) A. Kane et al. ONCOLOGIST
- Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival
- (2008) J D Wright et al. BRITISH JOURNAL OF CANCER
- Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy
- (2008) Nilofer S. Azad et al. CANCER
- CA 125, PET alone, PET–CT, CT and MRI in diagnosing recurrent ovarian carcinoma
- (2008) Ping Gu et al. EUROPEAN JOURNAL OF RADIOLOGY
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—A prospective study
- (2007) S. Risum et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More